Pain and itch connected down deep

A new study of itch adds to growing evidence that the chemical signals that make us want to scratch are the same signals that make us wince in pain.

The interactions between itch and are only partly understood, said itch and pain researcher Diana Bautista, an assistant professor of molecular and cell biology at the University of California, Berkeley. The skin contains some nerve cells that respond only to itch and others that respond only to pain. Others, however, respond to both, and some substances cause both itching and pain.

If itch and pain are closely linked, however, the implications are huge, Bautista said. If pain and itch use the same molecules to communicate with the , drugs now being developed to alleviate pain may also help quiet intractable itch.

"Some types of itch respond to antihistamines, but most itch, especially itch associated with like kidney and liver failure, and , does not," she said. "Even allergic itch only partly responds to antihistamines. We've shown that one of the drugs now being looked at by pharmaceutical companies as a pain reliever also blocks some types of histamine-independent itch."

Bautista's new research, published in this week's print edition of the journal Nature Neuroscience, shows that two specific irritants induce itching by way of the wasabi receptor, a pain receptor familiar to sushi lovers.

Other recent studies have shown that some itch inducers – called pruritogens – lead to activation of the capsaicin receptor, a pain receptor named for the incendiary chemical in chili peppers.

"It's starting to look like many pain are linked to the itch system," she said. "Both itch and pain use some of the same molecules to send signals to the brain."

Bautista has genetically altered mice so that they don't produce the wasabi receptor, and hopes that the mouse strain will help lead to a better understanding of forms of itch that do not respond to antihistamines.

Itch and pain aspects of touch

Pain and itch are extremes of our sense of touch, which itself is not well understood, Bautista said. While research has shown in detail how touch receptors on the skin map to the brain, "it's really an open question which molecules are involved in detecting tactile stimuli, like vibrations or light touch, and how these molecules are modulated."

In her lab, she applies a huge variety of chemical and physical stimuli to the skin in order to study and isolate the specific receptors that respond to such stimuli. She also grows skin cells and sensory neurons in dishes to probe them more thoroughly.

"One of the cool things about touch cells is you can put them in a dish, and you can poke them, and they'll respond to touch with an electrical signal," Bautista told the Daily Californian news outlet last year.

Five years ago, Bautista showed that allyl isothiocyanate, the sinus-clearing ingredient in wasabi, hot mustard and garlic, causes pain solely by activating a receptor called TRPA1 on sensory nerves. The receptor is one of a group of transient receptor potential (TRP) ion channels in sensory nerves under the skin, including the mouth and mucus membranes, which detect temperature, mechanical abrasion and irritating chemicals. The capsaicin and heat receptor, dubbed TRPV1, is another such ion channel, as is TRPM8, a cold-activated channel targeted by menthol and other cooling agents. When these receptors are activated, they open up and depolarize the nerve cell, which transmits an attention-grabbing pain signal through the spinal cord to the brain.

The pain work led to an interest in itch, and Bautista has accumulated a variety of agents that stimulate the itch reflex, including the plant called cowhage (Mucuna pruriens) and the drug chloroquine, an antimalarial that often causes a hellish, all-over itch. In some African countries up to 70 percent of the population develops itch from chloroquine, which causes many people to stop taking it.

Only between 5 and 20 percent of the skin's sensory nerves are sensitive to itch, and one group of them has histamine receptors that can be blocked by antihistamines to stop the itch. Both chloroquine and cowhage, however, cause a histamine-independent itch, as do opium compounds; inflammation, from asthma and allergies to skin rash; and eczema. These are currently untreatable and the focus of Bautista's research.

A common feature of itch receptors is that they are members of a family of G protein-coupled receptors widely used by the body to transmit signals from outside the cell into the cell interior. Bautista's colleague Xinzhong Dong in the Solomon H. Snyder Department of Neuroscience at Johns Hopkins University School of Medicine in Baltimore recently identified two new itch receptors, both of them Mas-related G protein-coupled receptors. One, MrgprA3, is stimulated by chloroquine, while the second, MrgprC11, is stimulated by BAM8-22, a peptide released by immune cells, including mast cells, during inflammation.

If sensory nerves contain pain receptors like TRPA1 and TRPV1, and itch receptors like MrgprA3 and MrgprC11, how does the cell distinguish between itch and pain? Bautista asked.

Focus on wasabi

Bautista tested both chloroquine and the mast cell chemical BAM8-22 on cultured mouse cells and found that both activate the wasabi receptor, TRPA1, causing a depolarization of . In addition, knock-out mice that lack the receptor do not respond to either chemical, while a chemical that blocks the receptor also stops the itch.

Her interpretation of the results is that in with both the chloroquine itch receptor and the wasabi pain receptor, when chloroquine binds to its receptor, it subsequently opens the wasabi receptor, which depolarizes the nerve cell and sends an itch signal to the brain. Similarly, in the cells that have both a BAM8-22 itch receptor and a wasabi receptor, BAM8-22 triggers opening of the wasabi receptor. Both itch inducers trigger the pain receptors through G protein couplings inside the cell.

"These experiments provide a wonderful demonstration that chloroquine and BAM8-22 cause itch only through the wasabi receptor," she said. "If both pathways converge on the same ion channel, perhaps other that cause itch also use this channel."

Related Stories

Burning pain and itching governed by same nerve cells

Nov 04, 2010

We all know how hard it is not to scratch when we have an itch. But how can an itch be alleviated? In a new study published today in the prestigious journal Neuron, researchers at Uppsala University present the surprising findin ...

Relief from itch seen in nerves; may aid treatment

Apr 06, 2009

(AP) -- Scratch an itch and you get ... aaaaaah. Now scientists have watched spinal nerves transmit that relief signal to the brain in monkeys, a possible step toward finding new treatments for persistent itching in people.

Research suggests why scratching is so relieving

Jan 31, 2008

In the first study to use imaging technology to see what goes on in the brain when we scratch, researchers at Wake Forest University Baptist Medical Center have uncovered new clues about why scratching may be so relieving ...

Recommended for you

Damage to brain networks affects stroke recovery

14 hours ago

(Medical Xpress)—Initial results of an innovative study may significantly change how some patients are evaluated after a stroke, according to researchers at Washington University School of Medicine in St. ...

Dopamine leaves its mark in brain scans

14 hours ago

Researchers use functional magnetic resonance imaging (fMRI) to identify which areas of the brain are active during specific tasks. The method reveals areas of the brain, in which energy use and hence oxygen ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.